Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-11
2011-01-11
Chong, Yong S (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S279000, C514S290000
Reexamination Certificate
active
07868015
ABSTRACT:
The present invention provides methods of treating cognitive deficits associated with mental retardation. The methods comprise combining cognitive training protocols and a general administration of phosphodiesterase 4 inhibitors.
REFERENCES:
patent: 5547979 (1996-08-01), Christensen, IV et al.
patent: 5817670 (1998-10-01), Takayama et al.
patent: 5847010 (1998-12-01), Hedgpeth et al.
patent: 5929223 (1999-07-01), Tully et al.
patent: 6051559 (2000-04-01), Tully et al.
patent: 6103718 (2000-08-01), Sterk
patent: 6458829 (2002-10-01), Shen et al.
patent: WO 96/11270 (1996-04-01), None
patent: WO 98/22137 (1998-05-01), None
patent: WO 00/14083 (2000-03-01), None
patent: WO 02/13867 (2002-02-01), None
patent: WO 2004/016227 (2004-02-01), None
Ahn, S. et al., “A Late Phase of Cerebellar Long-Term Depression requires Activation of CaMKIV and CREB,” Neron, 23: 559-568, 1991.
Bach, M.E. et al., “Age-Related Defects in Spatial Memory are Correlated with Defects in the Late Phase of Hippocampal Long-Term Potentiation in Vitro and are Attenuated by Drugs that Enhance the cAMP Signaling Pathway,” Proc. Natl. Acad. Sci. USA, 96: 5280-5285, 1999.
Barad, M. et al., “Rolipram, A Type IV-Specific Phosphodiesterase Inhibitor, Facilitates the Establishment of Long-Lasting Long-Term Potentiation and Improves Memory,” Proc. Natl. Acad. Sci. USA, 95: 15020-15025, 1998.
Bartsch, D. et al., “Aplysia CREB2 Represses Long-Terre Facolitation: Relief of Repression Converts Transient Facilitation into Long-Term Functional and Structural Change,” Cell, 83: 979-992, 1995.
Bellen, H.J., “The Fruit Fly: A Model Organism to Study the Genetics of Alcohol Abuse and Addiction?,” Call, 93: 909-912, 1998.
Berkow, R. (ed,), Merck Manual of Diagnosis and Therapy 1992, 16thed. (Merck & Co.), 1454-1456, 1992.
Bevilaqua, L. et al., “Drugs Acting Upon the Cyclic Adenosine Monophosphate/Protein Kinase a Signalling Pathway Modulate Memory Consolidation When Given Late After Training into Rat Hippocampus but not Amygdala,” Behavioural Pharmacology, 8:(4) 331-338, 1997.
Blendy, J.A., “Effects of Kainic Acid Induced Seizures on Immediate Early Gene Expression in Mice with a Targeted Mutation of the CREB Gene,” Brain Research, 681: 8-14, 1995.
Bourtchouladze, R. et al., “A Mouse Model of Rubinstein-Taybi Syndrome: Defective Long-Term Memory is Ameliorated by Inhibitors of Phosphodiesterase 4,” Proc. Nat'l Acad. Sci. USA, 100:(18) 10518-10522, 2003.
Bourtchouladze, R. et al., “Different Training Procedures Recruit Either One or Two Critical Periods for Contextual Memory Consolidation, Each of Which Requires Protein Synthesis and PKA,” Learning & Memory, 5: 365-374, 1998.
Bourtchuladze, R. et al., “Deficient Long-Term Memory in mice with a Targeted Mutation of the cAMP-Responsive Element-Binding Protein,” Cell, 79: 59-68, 1994.
Calandra, B. et al., “Dual Intracellular Signaling Pathways Mediated by the Human Cannabinoid CB1Receptor,” Eur. J. Pharmacol., 374: 445-455, 1999.
Calvanio et al., “Elements of Cognitive Rehabilitation After Right Hemisphere Stroke,” Neurol. Clin., 11:(1) 25-57, 1993.
Carlezon, W.A. et al., “Regulation of Cocaine Reward by CREB,” Science, 282: 2272-2275, 1998.
Constantinescu, A. et al., “Ethanol-Induced Translocation of cAMP-Dependent Protein Kinase to the Nucleus,” The Journal of Biological Chemistry, 274 (38): 26985-26991, 1999.
Dubnau, I. et al., “Gene discovery in Drosophila: New Insights for Learning and Memory,” Annu. Rev. Neurosci., 21: 407-444, 1998.
Glazewski, S. et al, “Impaired Experienced-Dependent Plasticity in Barrel Cortex of Mice Lacking the Alpha and Delta Isoforms of CREB,” Cerebral Cortex, 9: 249-256, 1999.
Guzowski, J.F. et al., “Antisense oligodeoxynucleotide-Mediated Disruption of Hippocampal cAMP Response Element Binding Protein Levels Impairs Consolidation of Memory for Water Maze Training,” Proc. Natl. Acad. Sci. USA, 94: 2693-2698, 1997.
Herring, A.C. et al., “Inhibition of the Cyclic AMP Signaling Cascade and Nuclear Factor Binding to CRE and κB Elements by Cannabinol, a Minimally CNS-Active Cannabinoid,” Biochemical Pharmacology, 55: 1013-1023, 1998.
Ikezu, T. et al., “Negative Transactivation of cAMP Response Element by Familial Alzheimer's Mutants of APP,” The EMBO Journal, 15(10): 2468-2475, 1996.
Impey, S. et al., “Induction of CRE-Mediated Gene Expression by Stimuli that Generate Long-Lasting LTP in Area CA1 of the Hippocampus,” Neuron, 16: 973-982, 1996.
Impey, S. et al., “Stimulation of cAMP Response element (CRE)-Mediated Transcription during Contextual Learning,” Nature Neuroscience, 1(7): 595-601, 1998.
Josselyn, S.A. et al., “Overexpression of CREB in the Amygdala Facilitates the Formation of Long-Term Memory Measured with Fear Potentiated Startle in Rats,” Society for Neuroscience, vol. 24, Abstract 365.10, 1998.
Katzung, Basic and Clinical Pharmacology, 195, 1995.
Kogan, J.H. et al., “Spaced Training Induces normal Long-Term Memory in CREB Mutant Mice,” Current Biology, 7: 1-11, 1996.
Lamprecht, R. et al., “cAMP Response Element-Binding Protein in the Amygdala is Required for Long-but not Short-Term Conditioned Taste Aversion Memory,” The Journal of Neuroscience, 17(21): 8443-8450, 1997.
Liu, P.C. et al., “Spatiotemporal Dynamics of CREB Phosphprylation: Transient Versus Sustained Phosphorylation in the Developing Striatum,” Neuron, 17: 1133-1144, 1996.
Milner, B. et al., “Cognitive Neuroscience and the Study of Memory,” Neuron, 20:(3) 445-468, 1998.
Moore, A.N. et al., “Neuronal Activity Increases the Phosphorylation of the Transcription Factor cAMP Response Element-Binding Protein (CREB) in Rat Hippocampus and Cortex,” The Journal of Biological Chemistry, 271(24): 14214-14220, 1996.
Moore, M.S. et al., “Ethanol Intoxication in Drosophila: Genetic and Pharmacological Evidence for Regulation by the cAMP Signaling Pathway,” Cell, 93: 997-1007, 1998.
Muratake, T. et al., “Immunohistochemical Changes of the Transcription Regulatory Factors in Rat Striatum after Methamphetamine Administration,” Ann. N.Y. Acad. Sci., 844: 21-26, 1998.
Murphy, D.D. et al., “Morphological Plasticity of Dendritic Spines in Central Neurons is Mediated by Activation of cAMP Response Element Binding Protein,” Proc. Natl. Acad. Sci. USA, 94: 1482-1487, 1997.
Pandey, S.C. et al., “Involvement of the Cyclic Amp-Responsive Element Binding Protein Gene Transcription Factor in Genetic Preference for Alcohol Drinking Behavior,” Alcohol. Clin. Exp. Res., 23(9): 1425-1434, 1999.
Pedreira, M.E., “Massed and spaced Training build up Different Components of Long-Term Habituation in the Crab Chasmagnathus,” Animal Learning & Behavior, 26(3): 34-45, 1998.
Pham, T.A. et al., “CRE-Mediated Gene Transcription in Neocortical Neuronal Plasticity during the Developmental Critical Period,” Neuron, 22: 63-72, 1999.
Sato, N. et al., “Elevated Amyloid β Protein (1-40) Level Induces CREB Phosphorylation at Serine-133 via p44/42 MAP Kinase (Erkl/2)-Dependent Pathway in Rat Pheochromocytoma PC12 Cells,” Biochemical and Biophysical Research Communications, 232: 637-642, 1997.
Silva, A.J. et al., “CREB and Memory,” Annu. Rev. Neurosci., 21: 127-148, 1998.
Tanaka, K. et al., “Temporal Profile of CREB Phosphorylation After Focal Ischemia in Rat Brain,” NeuroReport, 10: 2245-2250, 1999.
Tully, T. et al., “Genetic Dissection of Consolidated Memory in Drosophila,” Cell, 79: 35-47, 1994.
Widnell, K.L. et al., “Regulation of CREB Expression: In Vivo Evidence for a Functional Role in Morphine Action in the Nucleus Accleus,” J. Pharmacol. Exp. Ther, 276(1): 306-315, 1996.
Wong, S
Bourtchouladze Rusiko
Cavalieri Filippo
Tully Timothy P.
Chong Yong S
Cold Spring Harbor Laboratory
Pelto Don J.
Sheppard Mullin Richter & Hampton LLP
LandOfFree
Phosphodiesesterase 4 inhibitors for the treatment of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphodiesesterase 4 inhibitors for the treatment of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphodiesesterase 4 inhibitors for the treatment of a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2666659